Form 4: Q32 Bio Inc. Director Arthur Tzianabos Reports Stock Transactions

Director Arthur Tzianabos reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations following a reverse stock split.

Summary

• On March 25, 2024, Arthur Tzianabos, a director of Q32 Bio Inc., had restricted stock units vest, converting into 1,095 shares of common stock.
• Following the vesting, Tzianabos sold 265 shares at $24.2 to cover tax withholding obligations.
• These sales were automatic and not at the discretion of the reporting person.
• The transactions occurred after a 1-for-18 reverse stock split of Q32 Bio Inc.'s common stock on March 25, 2024.
• After these transactions, Tzianabos directly owns 7,983 shares of Q32 Bio Inc.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Management Comments

• The sales were automatic and not in the discretion of the Reporting Person.

Industry Context

Form 4 filings are standard disclosures required by the SEC for insiders (directors, officers, and 10% owners) of publicly traded companies, providing transparency into their transactions in the company's stock.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the sale of shares, but it is primarily related to tax obligations of the director.

Key Dates